terminal alkynes (Sonogashira coupling reaction) provides
us with an effective synthetic strategy for controlling the
dipolar orientation of pyrimidine in the conjugated backbone.
A very convenient one-pot consecutive Sonogashira coupling
procedure has been developed to introduce different alkynyl
groups at the 2- and 5-positions of pyrimidine.9 In the
presence of a catalytic amount of Pd(PPh3)4, 2 was synthe-
sized in 74% yield. 1,4-Diiodo-2,5-dioctylbezene was al-
lowed to react with 2 in the presence of Pd(PPh3)4 to provide
3 (54%). This new linear molecule 3 contains five aromatic
rings including two pyrimidine rings with two pairs of
nitrogen directed away from the central aryl linker (Scheme
1).
similar to 3 but with two pairs of pyrimidine nitrogens
directed toward the central aromatic linker, can be prepared
in 71% yield by coupling 4 with 1,3-di-tert-butyl-5-ethyn-
ylbenzene in the presence of the same catalyst at elevated
temperature (Scheme 2).
Scheme 2a
Scheme 1a
i
a (a) 1, Pd(PPh3)4, CuI, Pr2NH, THF, room temperature, 82%
i
(b) 1,3-di-tert-butyl-5-ethynylbenzene, Pd(PPh3)4, CuI, Pr2NH,
THF, reflux, 71%.
Synthetic pathways toward linear molecules possessing the
same arrangement of the dipolar orientation of pyrimidine
in the conjugated backbone are more complicated. First,
1-iodo-4-(trimethylsilylethynyl)-2,5-dioctylbenzene10 was
treated with 2 at 80 °C in the presence of Pd(PPh3)4 to afford
intermediate 6 in 94% yield. Removal of the TMS group
from 6 followed by coupling with 1 afforded 7 in 90% yield.
Further treatment of 7 with 1,3-di-tert-butyl-5-ethynylben-
zene in the presence of Pd catalyst gave the desired
compound 8 in 79% yield (Scheme 3).
a (a) i: 1,3-Di-tert-butyl-5-ethynylbenzene, Pd(PPh3)4, CuI,
iPr2NH, THF, 30 °C, ii: Me3SiCtCH, reflux, iii: 2 N NaOH, THF/
MeOH, 74%; (b) 1,4-diiodo-2,5-dioctylbenzene, Pd(PPh3)4, CuI,
iPr2NH, THF, reflux, 54%.
Treatment of 1 with 1,4-diethynyl-2,5-dioctylbezene in the
presence of Pd(PPh3)4 afforded dibromo compound 4 in 82%
yield after purification on silica gel. Linear molecule 5,
Scheme 3a
(7) Gommper, R.; Mari, H.-J.; Polborn, K. Synthesis 1997, 696. Kanbara,
T.; Kushida, T.; Saito, N.; Kuwajima, I.; Kubota, K.; Yamamoto, T. Chem.
Lett. 1992, 583.
(8) Goodby, J. W.; Hird, M. H.; Lewis, R. A.; Toyne, K. J. Chem.
Commun. 1996, 2719.
(9) One-pot consecutive coupling procedure: Under argon, a solution
of 5-bromo-2-iodopyrimidine (2.85 g, 10.0 mmol), Pd(PPh3)4 (580 mg, 0.5
i
mmol), CuI (100 mg, 0.5 mmol), and Pr2NH (2.67 mL, 19.0 mmol) in
THF (40 mL) was stirred for 3 min, and to this was added dropwisely over
a period of 3 mim 1,3-di-tert-butyl-5-ethynylbenzene (2.36 g, 11.0 mmol)
in THF (10 mL). The mixture was stirred for 2.5 h at 30 °C. Trimethyl-
i
silylacetylene (1.70 mL, 12.0 mmol) and Pr2NH (2.67 mL, 19.0 mmol)
were introduced quickly, and the mixture was heated to reflux for 1.5 h.
After cooling to room temperature, the ammonium salt formed was removed
by filtration through a short column of aluminum oxide and washed with
ether (2 × 20 mL). The combined filtrate was concentrated to dryness under
reduced pressure. The crude product was dissolved in THF (20 mL) and
methanol (10 mL), and to this solution was introduced 2.0 N NaOH (5
mL) to remove the silyl group in 20 min at room temperature. After
concentrating in vacuo, water (20 mL) was added, and the solution was
extracted with ether (2 × 25 mL). The combined organic solution was dried
(MgSO4) and concentrated. The residue was purified by column chroma-
tography on silica gel (EtOAc:hexanes ) 1:12) to afford 2 as pale yellow
solid (2.34 g, 74%): mp 202-204 °C; IR (KBr) 3274 (s), 2957 (m), 2219
(s), 1572 (m), 1414 (s), 1180 (m), 883 (m), 796 (m), 706 (m), 641 (m)
a (a) 1-Ethynyl-4-iodo-2,5-dioctylbenzene, Pd(PPh3)4, CuI, iPr2NH,
THF, room temperature, 94%; (b) i: 2 N NaOH, THF/MeOH, ii:
i
1, Pd(PPh3)4, CuI, Pr2NH, THF, room temperature, 90%; (c) 1,3-
di-tert-butyl-5-ethynylbenzene, Pd(PPh3)4, CuI, iPr2NH, THF, reflux,
1
cm-1; H NMR (CDCl3, 400 MHz) 1.32 (s, 18H), 3.47 (s, 1H), 7.49 (t, J
79%.
) 1.8 Hz, 1H), 7.55 (d, J ) 1.8 Hz, 2H), 8.81 (s, 2H); 13C NMR (CDCl3,
100 MHz) 31.5, 35.1, 85.8, 92.3, 116.1, 120.2, 124.8, 127.4, 151.3, 151.7,
159.9; MS (m/z, FAB+) 316 (100), 301 (15), 261 (9), 245 (6), 224 (4), 154
(15), 136 (11), 89 (4), 58 (25); HRMS cacld for C22H25N2 317.2018, found
317.2028. Anal. Cacld for C22H24N2: C, 83.50; H, 7.64; N, 8.85. Found:
C, 83.69; H, 7.38; N, 8.68.
Linear molecule 10 (Scheme 4) prepared in a similar
manner as that for 5 was employed as a reference compound.
174
Org. Lett., Vol. 3, No. 2, 2001